Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Oncology Letters
|
January 21, 2017
Ubiquitin specific protease 21 upregulation in breast cancer promotes cell tumorigenic capability and is associated with the NOD-like receptor signaling pathway
Liang Peng, Yi Hu, Demeng Chen, et al.
Journal of Environmental Management
|
October 1, 2023
Dynamic characteristics of net anthropogenic phosphorus input to the upper Yangtze River Basin from 1989 to 2019: Focus on the phosphate ore rich area in China
Junlan Yang, Min Li, Lu Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 11, 2016
GINS2 regulates matrix metallopeptidase 9 expression and cancer stem cell property in human triple negative Breast cancer
Liang Peng, Zhigang Song, Demeng Chen, et al.
Medicine
|
July 2, 2015
Epidemiological and Clinicopathological Trends of Breast Cancer in Chinese Patients During 1993 to 2013: A Retrospective Study
Wen Si, Ying Li, Yingjie Han, et al.
Breast Cancer Research : BCR
|
July 25, 2014
Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2-positive metastatic breast cancer patients treated with first-line lapatinib plus paclitaxel or paclitaxel alone
Binghe Xu, Zhongzhen Guan, Zhenzhou Shen, et al.
Experimental & Molecular Medicine
|
April 22, 2017
Inhibition of glutathione metabolism attenuates esophageal cancer progression
Liang Peng, Ruixia Linghu, Demeng Chen, et al.
Medicine
|
October 16, 2015
Docetaxel/S-1 Versus Docetaxel/Capecitabine as First-Line Treatment for Advanced Breast Cancer: A Retrospective Study
Jinyu Li, Junhao You, Wen Si, et al.
Oncology Reports
|
October 22, 2014
Specific growth inhibition of ErbB2‑expressing human breast cancer cells by genetically modified NK‑92 cells
Hui Liu, Bo Yang, Tingting Sun, et al.
Oncoimmunology
|
May 8, 2015
Combating HER2-overexpressing breast cancer through induction of calreticulin exposure by Tras-Permut CrossMab
Fan Zhang, Jie Zhang, Moyan Liu, et al.
Journal of Hematology & Oncology
|
August 13, 2016
Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients
Pin Zhang, Zhongsheng Tong, Fuguo Tian, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Oncology Letters
|
January 21, 2017
Ubiquitin specific protease 21 upregulation in breast cancer promotes cell tumorigenic capability and is associated with the NOD-like receptor signaling pathway
Liang Peng, Yi Hu, Demeng Chen, et al.
Journal of Environmental Management
|
October 1, 2023
Dynamic characteristics of net anthropogenic phosphorus input to the upper Yangtze River Basin from 1989 to 2019: Focus on the phosphate ore rich area in China
Junlan Yang, Min Li, Lu Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 11, 2016
GINS2 regulates matrix metallopeptidase 9 expression and cancer stem cell property in human triple negative Breast cancer
Liang Peng, Zhigang Song, Demeng Chen, et al.
Medicine
|
July 2, 2015
Epidemiological and Clinicopathological Trends of Breast Cancer in Chinese Patients During 1993 to 2013: A Retrospective Study
Wen Si, Ying Li, Yingjie Han, et al.
Breast Cancer Research : BCR
|
July 25, 2014
Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2-positive metastatic breast cancer patients treated with first-line lapatinib plus paclitaxel or paclitaxel alone
Binghe Xu, Zhongzhen Guan, Zhenzhou Shen, et al.
Experimental & Molecular Medicine
|
April 22, 2017
Inhibition of glutathione metabolism attenuates esophageal cancer progression
Liang Peng, Ruixia Linghu, Demeng Chen, et al.
Medicine
|
October 16, 2015
Docetaxel/S-1 Versus Docetaxel/Capecitabine as First-Line Treatment for Advanced Breast Cancer: A Retrospective Study
Jinyu Li, Junhao You, Wen Si, et al.
Oncology Reports
|
October 22, 2014
Specific growth inhibition of ErbB2‑expressing human breast cancer cells by genetically modified NK‑92 cells
Hui Liu, Bo Yang, Tingting Sun, et al.
Oncoimmunology
|
May 8, 2015
Combating HER2-overexpressing breast cancer through induction of calreticulin exposure by Tras-Permut CrossMab
Fan Zhang, Jie Zhang, Moyan Liu, et al.
Journal of Hematology & Oncology
|
August 13, 2016
Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients
Pin Zhang, Zhongsheng Tong, Fuguo Tian, et al.
Page
of 7